TNDM240719P47500
- 8.00
- -0.50-5.88%
Tandem Diabetes Care Newsroom
Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious
Wells Fargo Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $50
Wells Fargo analyst Larry Biegelsen maintains $Tandem Diabetes Care(TNDM.US)$ with a buy rating, and maintains the target price at $50.According to TipRanks data, the analyst has a success rate of 58.
Is weight loss medicine or stock market bomb? Eli Lilly and Co's new drug tirzepatide caused a sharp drop in sleep device stocks.
The recent clinical trial results of the new weight loss drug tirzepatide have not only caused a sensation in the medical community, but also stirred up waves in the stock market.
Tandem Diabetes, DexCom See Weakness Following ADA Conference
Lake Street Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $75
Lake Street analyst Brooks O'Neil maintains $Tandem Diabetes Care(TNDM.US)$ with a buy rating, and maintains the target price at $75.According to TipRanks data, the analyst has a success rate of 43.9%
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $45
TD Cowen analyst Josh Jennings maintains $Tandem Diabetes Care(TNDM.US)$ with a buy rating, and maintains the target price at $45.According to TipRanks data, the analyst has a success rate of 51.0% an
Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
PDF Version SAN DIEGO--(BUSINESS WIRE)--Jun. 22, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today presented new real-world insight
Tandem Diabetes Appoints Jean-Claude Kyrillos as COO
Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
PDF Version SAN DIEGO--(BUSINESS WIRE)--Jun. 20, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jea
Express News | Tandem Diabetes Care - Agreement Incorporates Integration of Co's Sigi Insulin Pump With Dexcom’s G7 Cgm Device, Extends Term for Period of 5 Years
Express News | Tandem Diabetes Care- on May 22, Co, Dexcom Entered Amended & Restated Development Agreement to Original Development Agreement, Dated Nov 20, 2020
Tandem Diabetes Care (NASDAQ:TNDM) Shareholders Are Still up 85% Over 1 Year Despite Pulling Back 5.5% in the Past Week
If you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right individual stocks, you could make more than that. For example, the Tandem Diabete
Oppenheimer Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $58
Oppenheimer analyst Steven Lichtman maintains $Tandem Diabetes Care(TNDM.US)$ with a buy rating, and adjusts the target price from $55 to $58.According to TipRanks data, the analyst has a success rate
Express News | Tandem Diabetes Care, Inc. : Oppenheimer Raises Target Price to $58 From $47
AMD To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Susquehanna
Tandem Diabetes Care Is Maintained at Outperform by Oppenheimer
Tandem Diabetes Care Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Outperform on Tandem Diabetes Care, Raises Price Target to $58
Oppenheimer analyst Steven Lichtman maintains Tandem Diabetes Care with a Outperform and raises the price target from $47 to $58.
Stocks With the Highest and Lowest Liquidity - Goldman Sachs
Tandem Diabetes Care(TNDM.US) Director Sells US$258.4K in Common Stock
$Tandem Diabetes Care(TNDM.US)$ Director Allen Dick sold 5,000 shares of common stock on May 30, 2024 at an average price of $51.68 for a total value of $258.4K.Source: Announcement What is statement
Tandem Diabetes Care Insider Sold Shares Worth $258,400, According to a Recent SEC Filing
Dick Allen, Director, on May 30, 2024, sold 5,000 shares in Tandem Diabetes Care (TNDM) for $258,400. Following the Form 4 filing with the SEC, Allen has control over a total of 47,288 shares of the c